Pediatric phase I trials in oncology: an analysis of study conduct efficiency.
about
Prospects and pitfalls of personalizing therapies for sarcomas: from children, adolescents, and young adults to the elderlyEarly phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective.Evaluation of agile designs in first-in-human (FIH) trials--a simulation studyAdolescent perspectives on phase I cancer researchPhase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors.Patient involvement in informed consent for pediatric phase I cancer research.Physician and nurse beliefs of phase 1 trials in pediatric oncology.Continual reassessment method vs. traditional empirically based design: modifications motivated by Phase I trials in pediatric oncology by the Pediatric Brain Tumor ConsortiumHope and persuasion by physicians during informed consent.Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experienceCommunication about the risks and benefits of phase I pediatric oncology trials.Improving access to novel agents for childhood leukemia.Practical communication guidance to improve phase 1 informed consent conversations and decision-making in pediatric oncologyPhase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumors.Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma.Does phase 1 trial enrollment preclude quality end-of-life care? Phase 1 trial enrollment and end-of-life care characteristics in children with cancerGood clinical practice and the conduct of clinical studies in pediatric oncology.Innovations for phase I dose-finding designs in pediatric oncology clinical trials.Phase I and Phase II Objective Response Rates are Correlated in Pediatric Cancer Trials: An Argument for Better Clinical Trial EfficiencyDiscrete event simulation applied to pediatric phase I oncology designs.Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas.The complexity of consenting to clinical research in phase I pediatric cancer studies.Understanding Treatment Burden and Quality of Life Impact of Participating in an Early-Phase Pediatric Oncology Clinical Trial: A Pilot Study.Participation in a clinical trial for a child with cancer is burdensome for a minority of children.A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials.Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational Agents.A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trials.Physician perceptions and beliefs of phase I trials in pediatric oncology.Low doses of monocrotaline in rats cause diminished bone marrow cellularity and compromised nitric oxide production by peritoneal macrophages.Outcome of children and adolescents with central nervous system tumors in phase I trials.Enrollment in early-phase clinical trials in pediatric oncology: The experience at Institut Curie.Joint adolescent-adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform-ACCELERATE.Bridging Adult Experience to Pediatrics in Oncology Drug Development.Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis.
P2860
Q27025344-11A9E34F-6BCC-43CC-9955-21939ED8D27CQ30234441-A306183E-0C3E-4360-8218-354B507A8D10Q30491850-B86C972B-BE0E-4DDE-8D36-378727A6C63BQ30531481-D6B81897-3DE1-4056-AB48-7A039807E8BCQ33416097-978743AB-51EB-4FDA-AB9B-41E269AEF3FCQ33976713-75489086-EEB9-46EC-BBCE-5171C0B1F3DDQ34072758-355A2F97-F179-4038-A153-0B13D433036CQ34292228-2297D3DF-5796-4FC8-81FC-CCB309D83182Q34682676-851C1C14-9305-4EB0-A71A-A87CDBEF3443Q34781347-4DCE45E1-EED9-44DB-82AE-8A4B3EEDEB24Q35496231-AED32C72-80FC-4EB9-B180-45F822D0C602Q35688742-33D31853-8BC2-48BB-917C-F2A1A24A5759Q35812000-39C245E0-E237-410B-B67D-2D197D784300Q36036684-D662B081-520D-450C-B2D9-8466D7D95754Q36250758-22EC56F6-BD89-498D-B56B-30D62B22EA8BQ36389862-22D44A4F-274C-4922-AA58-645956F126E5Q36513759-2889CDEB-BFDC-403A-A994-721055116132Q36757843-1DBAB07C-FA7D-4816-A6C7-DC2ED800FA80Q37048013-399B79A5-3754-4786-94ED-0F638264FCB1Q37299233-9B4FC3C2-7A89-4666-9F7E-30C497E1DF89Q37393469-04870DD7-2765-4E81-A3F5-566A40434011Q38312398-3CA3A26D-4EF0-4E30-87C7-A970E862179CQ38604209-2D986740-C148-42EC-8CC7-705552A5CB16Q38893159-6527AC88-FC56-4C23-91E8-8F1642646239Q38961012-4796C729-F66F-4E29-B0A1-034DEFBCADEDQ38990759-23461DB9-6622-4AEA-89BB-F4AF97FC4FCEQ40313777-BFC6F91B-DC30-4C36-85BC-A17F6E92CDA2Q44731845-02CF2145-3533-42DD-838F-4D9FD9DA7DAEQ45973154-6F367F61-049B-48A8-A580-C138A2E8D452Q47194256-2FB96129-B9C7-4359-BCA5-7B29489506FCQ48243845-EC3B6E71-1F11-4FAF-A6E7-33C548210A29Q48530699-FBA01270-DFD3-4A45-92F8-4879E3EE08BFQ50045460-C738F254-D7C8-4E8A-A3E1-71CE8C3FE496Q52692689-23355ED7-1389-483F-8144-3DC759FBB63E
P2860
Pediatric phase I trials in oncology: an analysis of study conduct efficiency.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pediatric phase I trials in oncology: an analysis of study conduct efficiency.
@ast
Pediatric phase I trials in oncology: an analysis of study conduct efficiency.
@en
type
label
Pediatric phase I trials in oncology: an analysis of study conduct efficiency.
@ast
Pediatric phase I trials in oncology: an analysis of study conduct efficiency.
@en
prefLabel
Pediatric phase I trials in oncology: an analysis of study conduct efficiency.
@ast
Pediatric phase I trials in oncology: an analysis of study conduct efficiency.
@en
P2093
P356
P1476
Pediatric phase I trials in oncology: an analysis of study conduct efficiency.
@en
P2093
Debra P Lee
Jeffrey M Skolnik
Peter C Adamson
P304
P356
10.1200/JCO.2005.02.1568
P407
P577
2005-11-01T00:00:00Z